erdafitinib,cetrelimab,enfortumab,Pembrolizumab,cisplatin,carboplatin,gemcitabine,atezolizumab
janssen,Astellas,Merck,Seagen,roche
['muc ,(-much)']
heartening to see substantial and meaningful progress in muc with these groundbreaking trials! #asco23 
medical oncology, genitourinary cancers